Photo by nci from unsplash
Article history: Received 15 November 2017 Accepted 15 November 2017 Available online 16 November 2017 example targeting Raf-1, Bcr, and Cdc25 phosphatase. Deguelin has the potential to impair 14-3-3 protein… Click to show full abstract
Article history: Received 15 November 2017 Accepted 15 November 2017 Available online 16 November 2017 example targeting Raf-1, Bcr, and Cdc25 phosphatase. Deguelin has the potential to impair 14-3-3 protein function through inhibition of Aurora B function.Deguelin can induce partial synchronization of cancer cells in the most radio-or DNA damaging agents-sensitive to G2-M phase, although it needs further work whether deguelin induced G2-M phase
Keywords:
november 2017;
tumorigenic agent;
anti tumorigenic;
novel anti;
deguelin;
deguelin novel
Journal Title: EBioMedicine
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: EBioMedicine
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!